Northwestern Mutual Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
MFM
PAI
Northwestern Mutual Wealth Management's IOVA Position: Q2 2026 in Review
Northwestern Mutual Wealth Management held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 1,880 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.
Northwestern Mutual Wealth Management first reported a position in IOVA in Q1 2021 and has held it in 22 quarters since. The position peaked at $27.9K in Q1 2024. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Northwestern Mutual Wealth Management held 1,880 shares of Iovance Biotherapeutics worth $7.82K as of Q2 2026.
- Northwestern Mutual Wealth Management left its Iovance Biotherapeutics share count unchanged in Q2 2026.
- Iovance Biotherapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3211 holding.
- Northwestern Mutual Wealth Management first reported a position in Iovance Biotherapeutics in Q1 2021 and has held it in 22 quarters since.
- Northwestern Mutual Wealth Management's Iovance Biotherapeutics position peaked at $27.9K in Q1 2024.
- 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.